ILK-IN-2
ILK-IN-2 (OSU-T315 analog) is an oral PDK2 inhibitor and also an ILK inhibitor, with an IC50 of 0.6 μM. ILK-IN-2 induces cell autophagy and apoptosis, showing anti-tumor activity. ILK-IN-2 directly abolishes AKT activation by preventing AKT from translocating to lipid rafts, triggering Caspase-dependent apoptosis in chronic lymphocytic leukemia (CLL) and extending the lifespan in TCL1 mouse models[1][2].
Product Specifications
CAS Number
1333146-24-9
Product Name Alternative
OSU-T315 analog
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Ser/Thr Kinase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/ILK-IN-2.html
Purity
99.41
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
O=C(NC)CCC1=NN(C2=CC=C(N3CCNCC3)C=C2)C(C4=CC=C(C5=CC=C(C(F)(F)F)C=C5)C=C4)=C1
Molecular Formula
C30H30F3N5O
Molecular Weight
533.59
Precautions
H302, H315, H319, H335
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Mouse Anti-Human CD8 Monoclonal Antibody,Azide Free Clone B-Z31
Mouse Anti-Human CD8 Monoclonal Antibody,Azide Free Clone B-Z31
Mouse Anti-Human CD8 Monoclonal Antibody,Azide Free Clone B-Z31
Cavy PAS Domain-Containing Serine/Threonine-Protein Kinase (PASK) ELISA Kit
